Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Harayama, T; Akamatsu, H; Okamura, K; Miyagoe, T; Akiyama, T; Abe, H; Takeuchi, Y
   Synthesis of trisphaeridine and norchelerythrine through palladium-catalyzed aryl-aryl coupling reaction
   JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
   
   T. Harayama et al., "Synthesis of trisphaeridine and norchelerythrine through palladium-catalyzed aryl-aryl coupling reaction", J CHEM S P1, (5), 2001, pp. 523-528
2. Palumbo, M; Sissi, C; Gatto, B; Moro, S; Zagotto, G
   Quantitation of camptothecin and related compounds
   JOURNAL OF CHROMATOGRAPHY B
   
   M. Palumbo et al., "Quantitation of camptothecin and related compounds", J CHROMAT B, 764(1-2), 2001, pp. 121-140
3. Zufia, L; Aldaz, A; Giraldez, J
   Separation methods for camptothecin and related compounds
   JOURNAL OF CHROMATOGRAPHY B
   
   L. Zufia et al., "Separation methods for camptothecin and related compounds", J CHROMAT B, 764(1-2), 2001, pp. 141-159
4. Balestrazzi, A; Bernacchia, G; Pitto, L; Luccarini, G; Carbonera, D
   Spatial expression of DNA topoisomerase I genes during cell proliferation in Daucus carota
   EUROPEAN JOURNAL OF HISTOCHEMISTRY
   
   A. Balestrazzi et al., "Spatial expression of DNA topoisomerase I genes during cell proliferation in Daucus carota", EUR J HIST, 45(1), 2001, pp. 31-38
5. Takebayashi, Y; Pourquier, P; Zimonjic, DB; Nakayama, K; Emmert, S; Ueda, T; Urasaki, Y; Kanzaki, A; Akiyama, S; Popescu, N; Kraemer, KH; Pommier, Y
   Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair
   NATURE MEDICINE
   
   Y. Takebayashi et al., "Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair", NAT MED, 7(8), 2001, pp. 961-966
6. Kirstein, MN; Houghton, PJ; Cheshire, PJ; Richmond, LB; Smith, AK; Hanna, SK; Stewart, CF
   Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts
   CLINICAL CANCER RESEARCH
   
   M.N. Kirstein et al., "Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts", CLIN CANC R, 7(2), 2001, pp. 358-366
7. Minami, H; Fujii, H; Igarashi, T; Itoh, K; Tamanoi, K; Oguma, T; Sasaki, Y
   Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks
   CLINICAL CANCER RESEARCH
   
   H. Minami et al., "Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks", CLIN CANC R, 7(10), 2001, pp. 3056-3064
8. Jagasia, MH; Langer, CJ; Johnson, DH; Yunus, F; Rodgers, JS; Schlabach, LL; Cohen, AG; Shyr, Y; Carbone, DP; DeVore, RF
   Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study
   CLINICAL CANCER RESEARCH
   
   M.H. Jagasia et al., "Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study", CLIN CANC R, 7(1), 2001, pp. 68-73
9. Makinsky, AA; Kritzyn, AM; Ul'yanova, EA; Zakharova, OD; Bugreev, DV; Nevinsky, GA
   Polymethylene derivatives of nucleic bases with omega-functional groups: II. Adenine and hypoxanthine derivatives
   RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
   
   A.A. Makinsky et al., "Polymethylene derivatives of nucleic bases with omega-functional groups: II. Adenine and hypoxanthine derivatives", RUS J BIOOR, 27(3), 2001, pp. 167-172
10. Shav-Tal, Y; Cohen, M; Lapter, S; Dye, B; Patton, JG; Vandekerckhove, J; Zipori, D
    Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changesin protein interactions
    MOLECULAR BIOLOGY OF THE CELL
    
    Y. Shav-Tal et al., "Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changesin protein interactions", MOL BIOL CE, 12(8), 2001, pp. 2328-2340
11. Dallavalle, S; Ferrari, A; Merlini, L; Penco, S; Carenini, N; De Cesare, M; Perego, P; Pratesi, G; Zunino, F
    Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    S. Dallavalle et al., "Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin", BIOORG MED, 11(3), 2001, pp. 291-294
12. Guichard, S; Arnould, S; Hennebelle, I; Bugat, R; Canal, P
    Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo
    ANTI-CANCER DRUGS
    
    S. Guichard et al., "Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo", ANTI-CANC D, 12(9), 2001, pp. 741-751
13. Cordell, GA; Quinn-Beattie, ML; Farnsworth, NR
    The potential of alkaloids in drug discovery
    PHYTOTHERAPY RESEARCH
    
    G.A. Cordell et al., "The potential of alkaloids in drug discovery", PHYTOTHER R, 15(3), 2001, pp. 183-205
14. Sanz-Altamira, PM; O'Reilly, E; Stuart, KE; Raeburn, L; Steger, C; Kemeny, NE; Saltz, LB
    A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma
    ANNALS OF ONCOLOGY
    
    P.M. Sanz-Altamira et al., "A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma", ANN ONCOL, 12(4), 2001, pp. 501-504
15. Rich, TA; Kirichenko, AV
    Camptothecin schedule and timing of administration with irradiation
    ONCOLOGY-NEW YORK
    
    T.A. Rich e A.V. Kirichenko, "Camptothecin schedule and timing of administration with irradiation", ONCOLOGY-NY, 15(3), 2001, pp. 37-41
16. Gonzalez, IL; Sylvester, JE
    Human rDNA: Evolutionary patterns within the genes and tandem arrays derived from multiple chromosomes
    GENOMICS
    
    I.L. Gonzalez e J.E. Sylvester, "Human rDNA: Evolutionary patterns within the genes and tandem arrays derived from multiple chromosomes", GENOMICS, 73(3), 2001, pp. 255-263
17. Royce, ME; Hoff, PM; Dumas, P; Lassere, Y; Lee, JJ; Coyle, J; Ducharme, MP; De Jager, R; Pazdur, R
    Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): A novelcamptothecin analog
    JOURNAL OF CLINICAL ONCOLOGY
    
    M.E. Royce et al., "Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): A novelcamptothecin analog", J CL ONCOL, 19(5), 2001, pp. 1493-1500
18. Vanhoefer, U; Harstrick, A; Achterrath, W; Cao, SS; Seeber, S; Rustum, YM
    Irinotecan in the treatment of colorectal cancer: Clinical overview
    JOURNAL OF CLINICAL ONCOLOGY
    
    U. Vanhoefer et al., "Irinotecan in the treatment of colorectal cancer: Clinical overview", J CL ONCOL, 19(5), 2001, pp. 1501-1518
19. Socinski, MA; Sandler, AB; Miller, LL; Locker, PK; Hanover, CK; Elfring, GL; Israel, VK; Pirotta, N; Natale, RB
    Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    M.A. Socinski et al., "Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer", J CL ONCOL, 19(4), 2001, pp. 1078-1087
20. Fisher, BJ; Scott, C; Macdonald, DR; Coughlin, C; Curran, WJ
    Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507
    JOURNAL OF CLINICAL ONCOLOGY
    
    B.J. Fisher et al., "Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507", J CL ONCOL, 19(4), 2001, pp. 1111-1117
21. Biswas, A; Dey, J
    Ground and excited-state ionization behavior of 9-aminocamptothecin: An absorption and fluorescence spectral study
    INDIAN JOURNAL OF CHEMISTRY SECTION A-INORGANIC BIO-INORGANIC PHYSICAL THEORETICAL & ANALYTICAL CHEMISTRY
    
    A. Biswas e J. Dey, "Ground and excited-state ionization behavior of 9-aminocamptothecin: An absorption and fluorescence spectral study", I J CHEM A, 40(11), 2001, pp. 1143-1148
22. Shigeoka, Y; Itoh, K; Igarashi, T; Ishizawa, K; Saeki, T; Fujii, H; Minami, H; Imoto, S; Sasaki, Y
    Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    
    Y. Shigeoka et al., "Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens", JPN J CLIN, 31(8), 2001, pp. 370-374
23. Kim, Y; You, YJ; Ahn, BZ
    Naphthazarin derivatives (VIII): Synthesis, inhibitory effect on DNA topoisomerase-I, and antiproliferative activity of 6-(1-acyloxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones
    ARCHIV DER PHARMAZIE
    
    Y. Kim et al., "Naphthazarin derivatives (VIII): Synthesis, inhibitory effect on DNA topoisomerase-I, and antiproliferative activity of 6-(1-acyloxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones", ARCH PHARM, 334(10), 2001, pp. 318-322
24. Bahadori, HR; Green, MR; Catapano, CV
    Synergistic interaction between topotecan and microtubule-interfering agents
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    H.R. Bahadori et al., "Synergistic interaction between topotecan and microtubule-interfering agents", CANC CHEMOT, 48(3), 2001, pp. 188-196
25. Thomas, RR; Dahut, W; Harold, N; Grem, JL; Monahan, BP; Liang, M; Band, RA; Cottrell, J; Llorens, V; Smith, JA; Corse, W; Arbuck, SG; Wright, J; Chen, AP; Hamilton, JM; Allegra, CJ; Takimoto, CH
    A phase I and pharmacologic study of 9-aminocamptothecin administered as a120-h infusion weekly to adult cancer patients
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    R.R. Thomas et al., "A phase I and pharmacologic study of 9-aminocamptothecin administered as a120-h infusion weekly to adult cancer patients", CANC CHEMOT, 48(3), 2001, pp. 215-222
26. Kang, SH; Park, MH; Song, EY; Kang, SJ; Lee, EB; Song, YW; Takeuchi, F
    Association of HLA class II genes with systemic sclerosis in Koreans
    JOURNAL OF RHEUMATOLOGY
    
    S.H. Kang et al., "Association of HLA class II genes with systemic sclerosis in Koreans", J RHEUMATOL, 28(7), 2001, pp. 1577-1583
27. Kim, SH; Kang, IC; Yoon, TJ; Park, YM; Kang, KS; Song, GY; Ahn, BZ
    Antitumor activities of a newly synthesized shikonin derivative, 2-hyim-DMNQ-S-33
    CANCER LETTERS
    
    S.H. Kim et al., "Antitumor activities of a newly synthesized shikonin derivative, 2-hyim-DMNQ-S-33", CANCER LETT, 172(2), 2001, pp. 171-175
28. Allemand, E; Gattoni, R; Bourbon, HM; Stevenin, J; Caceres, JF; Soret, J; Tazi, J
    Distinctive features of Drosophila alternative splicing factor RS domain: Implication for specific phosphorylation, shuttling, and splicing activation
    MOLECULAR AND CELLULAR BIOLOGY
    
    E. Allemand et al., "Distinctive features of Drosophila alternative splicing factor RS domain: Implication for specific phosphorylation, shuttling, and splicing activation", MOL CELL B, 21(4), 2001, pp. 1345-1359
29. Topcu, Z
    DNA topoisomerases as targets for anticancer drugs
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    
    Z. Topcu, "DNA topoisomerases as targets for anticancer drugs", J CLIN PH T, 26(6), 2001, pp. 405-416
30. Song, GY; Kim, Y; You, YJ; Cho, H; Ahn, BZ
    Naphthazarin derivatives (VII): Antitumor action against ICR mise bearing ascitic S-180 cells
    ARCHIVES OF PHARMACAL RESEARCH
    
    G.Y. Song et al., "Naphthazarin derivatives (VII): Antitumor action against ICR mise bearing ascitic S-180 cells", ARCH PH RES, 24(3), 2001, pp. 190-193
31. Song, GY; Kim, Y; You, YJ; Cho, H; Ahn, BZ
    Naphthazarin derivatives (VII): Antitumor action against ICR mice bearing ascitic S-180 cells
    ARCHIVES OF PHARMACAL RESEARCH
    
    G.Y. Song et al., "Naphthazarin derivatives (VII): Antitumor action against ICR mice bearing ascitic S-180 cells", ARCH PH RES, 24(1), 2001, pp. 35-38
32. Sidorik, LL; Todurov, IM; Vigontina, OG; Rybkinska, TA; Vudmaska, MI; Naydenov, VG; Kopchak, VM; Matsuka, GC
    Antibodies against DNA topoisomerase I in blood serum of patients with pathologies of pancreas
    EXPERIMENTAL ONCOLOGY
    
    L.L. Sidorik et al., "Antibodies against DNA topoisomerase I in blood serum of patients with pathologies of pancreas", EXP ONCOL, 23(3), 2001, pp. 153-156
33. Turker, L
    A theoretical study on camptothecin-AM1 treatment
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
    
    L. Turker, "A theoretical study on camptothecin-AM1 treatment", J MOL ST-TH, 549(3), 2001, pp. 275-283
34. Grivicich, I; Mans, DRA; Peters, GJ; Schwartsmann, G
    Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    
    I. Grivicich et al., "Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer", BRAZ J MED, 34(9), 2001, pp. 1087-1103
35. Zhang, XB; Kiechle, F
    Hoechst 33342-induced apoptosis is associated with decreased immunoreactive topoisomerase I and topoisomerase I-DNA complex formation
    ANNALS OF CLINICAL AND LABORATORY SCIENCE
    
    X.B. Zhang e F. Kiechle, "Hoechst 33342-induced apoptosis is associated with decreased immunoreactive topoisomerase I and topoisomerase I-DNA complex formation", ANN CLIN L, 31(2), 2001, pp. 187-198
36. Dumas, C; Royer, J; Husson, HP
    Partial synthesis of camptothecin analogs. Part 3: Easy approach to a quinoline-lactone system
    TETRAHEDRON LETTERS
    
    C. Dumas et al., "Partial synthesis of camptothecin analogs. Part 3: Easy approach to a quinoline-lactone system", TETRAHEDR L, 42(51), 2001, pp. 8973-8975
37. Harayama, T; Akiyama, T; Akamatsu, H; Kawano, K; Abe, H; Takeuchi, Y
    Total synthesis of benzo[c]phenanthridine alkaloids, chelerythrine and 12-methoxydihydrochelerythrine, by a palladium-assisted internal biaryl coupling reaction
    SYNTHESIS-STUTTGART
    
    T. Harayama et al., "Total synthesis of benzo[c]phenanthridine alkaloids, chelerythrine and 12-methoxydihydrochelerythrine, by a palladium-assisted internal biaryl coupling reaction", SYNTHESIS-S, (3), 2001, pp. 444-450
38. Strel'tsov, SA; Grokhovskii, SL; Kudelina, IA; Oleinikov, VA; Zhuze, AL
    Interaction of topotecan, DNA tapoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. 1. Topotecan dimerization in solution
    MOLECULAR BIOLOGY
    
    S.A. Strel'tsov et al., "Interaction of topotecan, DNA tapoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. 1. Topotecan dimerization in solution", MOL BIOL, 35(3), 2001, pp. 365-373
39. Fan, Y; Shi, LM; Kohn, KW; Pommier, Y; Weinstein, JN
    Quantitative structure-antitumor activity relationships of camptothecin analogues: Cluster analysis and genetic algorithm-based studies
    JOURNAL OF MEDICINAL CHEMISTRY
    
    Y. Fan et al., "Quantitative structure-antitumor activity relationships of camptothecin analogues: Cluster analysis and genetic algorithm-based studies", J MED CHEM, 44(20), 2001, pp. 3254-3263
40. Dallavalle, S; Ferrari, A; Biasotti, B; Merlini, L; Penco, S; Gallo, G; Marzi, M; Tinti, MO; Martinelli, R; Pisano, C; Carminati, P; Carenini, N; Beretta, G; Perego, P; De Cesare, M; Pratesi, G; Zunino, F
    Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity
    JOURNAL OF MEDICINAL CHEMISTRY
    
    S. Dallavalle et al., "Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity", J MED CHEM, 44(20), 2001, pp. 3264-3274
41. Kim, DK; Ryu, DH; Lee, JY; Lee, N; Kim, YW; Kim, JS; Chang, K; Im, GJ; Kim, TK; Choi, WS
    Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues
    JOURNAL OF MEDICINAL CHEMISTRY
    
    D.K. Kim et al., "Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues", J MED CHEM, 44(10), 2001, pp. 1594-1602
42. Kuwana, M; Okano, T; Ogawa, Y; Kaburaki, J; Kawakami, Y
    Autoantibodies to the amino-terminal fragment of beta-fodrin expressed in glandular epithelial cells in patients with Sjogren's syndrome
    JOURNAL OF IMMUNOLOGY
    
    M. Kuwana et al., "Autoantibodies to the amino-terminal fragment of beta-fodrin expressed in glandular epithelial cells in patients with Sjogren's syndrome", J IMMUNOL, 167(9), 2001, pp. 5449-5456
43. Zhou, XD; Tan, FK; Xiong, MM; Milewicz, DM; Feghali, CA; Fritzler, MJ; Reveille, JD; Arnett, FC
    Systemic sclerosis (scleroderma): Specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts
    JOURNAL OF IMMUNOLOGY
    
    X.D. Zhou et al., "Systemic sclerosis (scleroderma): Specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts", J IMMUNOL, 167(12), 2001, pp. 7126-7133
44. Kuwana, M; Kaburaki, J; Wright, TM; Kawakami, Y; Ikeda, Y
    Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    M. Kuwana et al., "Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors", EUR J IMMUN, 31(9), 2001, pp. 2547-2557
45. Larsen, AK; Gilbert, C; Chyzak, G; Plisov, SY; Naguibneva, I; Lavergne, O; Lesueur-Ginot, L; Bigg, DCH
    Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells
    CANCER RESEARCH
    
    A.K. Larsen et al., "Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells", CANCER RES, 61(7), 2001, pp. 2961-2967
46. Erlichman, C; Boerner, SA; Hallgren, CG; Spieker, R; Wang, XY; James, CD; Scheffer, GL; Maliepaard, M; Ross, DD; Bible, KC; Kaufmann, SH
    The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistanceprotein-mediated drug efflux
    CANCER RESEARCH
    
    C. Erlichman et al., "The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistanceprotein-mediated drug efflux", CANCER RES, 61(2), 2001, pp. 739-748
47. De Cesare, M; Pratesi, G; Perego, P; Carenini, N; Tinelli, S; Merlini, L; Penco, S; Pisano, C; Bucci, F; Vesci, L; Pace, S; Capocasa, F; Carminati, P; Zunino, F
    Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin
    CANCER RESEARCH
    
    M. De Cesare et al., "Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin", CANCER RES, 61(19), 2001, pp. 7189-7195
48. Pilch, B; Allemand, E; Facompre, M; Bailly, C; Riou, JF; Soret, J; Tazi, J
    Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506
    CANCER RESEARCH
    
    B. Pilch et al., "Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506", CANCER RES, 61(18), 2001, pp. 6876-6884
49. Tsai, TH; Lee, CH; Yeh, PH
    Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis
    BRITISH JOURNAL OF PHARMACOLOGY
    
    T.H. Tsai et al., "Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis", BR J PHARM, 134(6), 2001, pp. 1245-1252
50. Arai, T; Yoshida, K; Kaburaki, J; Inoko, H; Ikeda, Y; Kawakami, Y; Kuwana, M
    Autoreactive CD4(+) T-cell clones to beta 2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site
    BLOOD
    
    T. Arai et al., "Autoreactive CD4(+) T-cell clones to beta 2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site", BLOOD, 98(6), 2001, pp. 1889-1896
51. Kuwana, M; Kaburaki, J; Kitasato, H; Kato, M; Kawai, S; Kawakami, Y; Ikeda, Y
    Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura
    BLOOD
    
    M. Kuwana et al., "Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura", BLOOD, 98(1), 2001, pp. 130-139
52. Brehm, BR; Bock, C; Wesselborg, S; Pfeiffer, S; Schuler, S; Schulz-Osthoff, K
    Prevention of human smooth muscle cell proliferation without induction of apoptosis by the topoisomerase I inhibitor topotecan
    BIOCHEMICAL PHARMACOLOGY
    
    B.R. Brehm et al., "Prevention of human smooth muscle cell proliferation without induction of apoptosis by the topoisomerase I inhibitor topotecan", BIOCH PHARM, 61(1), 2001, pp. 119-127
53. Borioli, GA; Caputto, BL; Maggio, B
    c-Fos is surface active and interacts differentially with phospholipid monolayers
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    G.A. Borioli et al., "c-Fos is surface active and interacts differentially with phospholipid monolayers", BIOC BIOP R, 280(1), 2001, pp. 9-13
54. Hochberg, F; Grossman, SA; Mikkelsen, T; Glantz, M; Fisher, JD; Piantadosi, S
    Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma
    NEURO-ONCOLOGY
    
    F. Hochberg et al., "Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma", NEURO-ONCOL, 2(1), 2000, pp. 29-33
55. Utz, PJ; Gensler, TJ; Anderson, P
    Death, autoantigen modifications, and tolerance
    ARTHRITIS RESEARCH
    
    P.J. Utz et al., "Death, autoantigen modifications, and tolerance", ARTHRITIS R, 2(2), 2000, pp. 101-114
56. Carmo-Fonseca, M; Mendes-Soares, L; Campos, I
    To be or not to be in the nucleolus
    NATURE CELL BIOLOGY
    
    M. Carmo-Fonseca et al., "To be or not to be in the nucleolus", NAT CELL BI, 2(6), 2000, pp. E107-E112
57. Escoriaza, J; Aldaz, A; Castellanos, C; Calvo, E; Giraldez, J
    Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies
    JOURNAL OF CHROMATOGRAPHY B
    
    J. Escoriaza et al., "Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies", J CHROMAT B, 740(2), 2000, pp. 159-168
58. Pichierri, P; Franchitto, A; Mosesso, P; Palitti, F
    Werner's syndrome cell lines are hypersensitive to camptothecin-induced chromosomal damage
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    
    P. Pichierri et al., "Werner's syndrome cell lines are hypersensitive to camptothecin-induced chromosomal damage", MUT RES-F M, 456(1-2), 2000, pp. 45-57
59. Mosesso, P; Pichierri, P; Franchitto, A; Palitti, F
    Evidence that camptothecin-induced aberrations in the G(2) phase of cell cycle of Chinese hamster ovary (CHO) cell lines is associated with transcription
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    
    P. Mosesso et al., "Evidence that camptothecin-induced aberrations in the G(2) phase of cell cycle of Chinese hamster ovary (CHO) cell lines is associated with transcription", MUT RES-F M, 452(2), 2000, pp. 189-195
60. Sukardiman; Darwanto, A; Tanjung, M; Darmadi, MO
    Cytotoxic mechanism of flavonoid from Temu Kunci (Kaempferia pandurata) incell culture of human mammary carcinoma
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    
    Sukardiman et al., "Cytotoxic mechanism of flavonoid from Temu Kunci (Kaempferia pandurata) incell culture of human mammary carcinoma", CL HEMORH M, 23(2-4), 2000, pp. 185-190
61. Utz, PJ; Anderson, P
    Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules
    CELL DEATH AND DIFFERENTIATION
    
    P.J. Utz e P. Anderson, "Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules", CELL DEAT D, 7(7), 2000, pp. 589-602
62. Vogelauer, M; Cioci, F; Bordi, L; Camilloni, G
    In vivo studies of the non-transcribed spacer region of rDNA in Saccharomyces cerevisiae
    FOOD TECHNOLOGY AND BIOTECHNOLOGY
    
    M. Vogelauer et al., "In vivo studies of the non-transcribed spacer region of rDNA in Saccharomyces cerevisiae", FOOD TECH B, 38(4), 2000, pp. 315-321
63. Fulco, RA; Costa, C; Germano, MP; Torre, EA; Viscomi, MG; Salimbeni, V; Maisano, R; Giudice, A; Costa, G
    Hepatotoxicity of camptothecin derivatives in a primary culture system of rat hepatocytes
    JOURNAL OF CHEMOTHERAPY
    
    R.A. Fulco et al., "Hepatotoxicity of camptothecin derivatives in a primary culture system of rat hepatocytes", J CHEMOTHER, 12(4), 2000, pp. 345-351
64. Santos, A; Zanetta, S; Cresteil, T; Deroussent, A; Pein, F; Raymond, E; Vernillet, L; Risse, ML; Boige, V; Gouyette, A; Vassal, G
    Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans
    CLINICAL CANCER RESEARCH
    
    A. Santos et al., "Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans", CLIN CANC R, 6(5), 2000, pp. 2012-2020
65. Moutsopoulos, NM; Routsias, JG; Vlachoyiannopoulos, PG; Tzioufas, AG; Moutsopoulos, HM
    B-cell epitopes of intracellular autoantigens: Myth and reality
    MOLECULAR MEDICINE
    
    N.M. Moutsopoulos et al., "B-cell epitopes of intracellular autoantigens: Myth and reality", MOL MED, 6(3), 2000, pp. 141-151
66. Tan, FK; Arnett, FC
    Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon
    CURRENT OPINION IN RHEUMATOLOGY
    
    F.K. Tan e F.C. Arnett, "Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon", CURR OP RH, 12(6), 2000, pp. 511-519
67. Werbovetz, KA; Bhattacharjee, AK; Brendle, JJ; Scovill, JP
    Analysis of stereoelectronic properties of camptothecin analogues in relation to biological activity
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    K.A. Werbovetz et al., "Analysis of stereoelectronic properties of camptothecin analogues in relation to biological activity", BIO MED CH, 8(7), 2000, pp. 1741-1747
68. Ferlin, MG; Gatto, B; Chiarelotto, G; Palumbo, M
    Pyrrolo-quinoline derivatives as potential antineoplastic drugs
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    M.G. Ferlin et al., "Pyrrolo-quinoline derivatives as potential antineoplastic drugs", BIO MED CH, 8(6), 2000, pp. 1415-1422
69. Uhlmann, F
    Chromosome cohesion: A polymerase for chromosome bridges
    CURRENT BIOLOGY
    
    F. Uhlmann, "Chromosome cohesion: A polymerase for chromosome bridges", CURR BIOL, 10(19), 2000, pp. R698-R700
70. Verweij, J; de Jonge, MJA
    Achievements and future of chemotherapy
    EUROPEAN JOURNAL OF CANCER
    
    J. Verweij e M.J.A. de Jonge, "Achievements and future of chemotherapy", EUR J CANC, 36(12), 2000, pp. 1479-1487
71. Gornet, JM; Azoulay, D; Levi, F; Yovine, A; Misset, JL; Goldwasser, F
    Dramatic tumor response of bulky liver metastases following treatment withCPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient
    ANTI-CANCER DRUGS
    
    J.M. Gornet et al., "Dramatic tumor response of bulky liver metastases following treatment withCPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient", ANTI-CANC D, 11(4), 2000, pp. 263-268
72. Boabang, P; Kurbacher, CM; Kohlhagen, H; Waida, A; Amo-Takyi, BK
    Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay
    ANTI-CANCER DRUGS
    
    P. Boabang et al., "Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay", ANTI-CANC D, 11(10), 2000, pp. 843-848
73. Vicario, JL; Badia, D; Dominguez, E; Carrillo, L
    Stereocontrolled synthesis of 2-aryl tetralones. Application in the synthesis of B/C hexahydrobenzo[c]phenanthridine alkaloids
    TETRAHEDRON-ASYMMETRY
    
    J.L. Vicario et al., "Stereocontrolled synthesis of 2-aryl tetralones. Application in the synthesis of B/C hexahydrobenzo[c]phenanthridine alkaloids", TETRAHEDR-A, 11(5), 2000, pp. 1227-1237
74. Goossens, JF; Henichart, JP; Dassonneville, L; Facompre, M; Bailly, C
    Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    
    J.F. Goossens et al., "Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells", EUR J PH SC, 10(2), 2000, pp. 125-131
75. Maiello, E; Gebbia, V; Giuliani, F; Paoletti, G; Gebbia, N; Cigolari, S; Fortunato, S; Pedicini, T; Borsellino, N; Lopez, M; Colucci, G
    5-fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group
    ANNALS OF ONCOLOGY
    
    E. Maiello et al., "5-fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group", ANN ONCOL, 11(8), 2000, pp. 1045-1051
76. Sorensen, M; Jensen, PB; Herrstedt, J; Hirsch, FR; Hansen, HH
    A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer
    ANNALS OF ONCOLOGY
    
    M. Sorensen et al., "A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer", ANN ONCOL, 11(7), 2000, pp. 829-835
77. Daigle, F; Forget, C; Martin, C; Drolet, M; Tessier, MC; Dezfulian, H; Harel, J
    Effects of global regulatory proteins and environmental conditions on fimbrial gene expression of F165(1) and F165(2) produced by Escherichia coli causing septicaemia in pigs
    RESEARCH IN MICROBIOLOGY
    
    F. Daigle et al., "Effects of global regulatory proteins and environmental conditions on fimbrial gene expression of F165(1) and F165(2) produced by Escherichia coli causing septicaemia in pigs", RES MICROB, 151(7), 2000, pp. 563-574
78. Yanase, K; Sugimoto, Y; Tsukahara, S; Oh-hara, T; Andoh, T; Tsuruo, T
    Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    K. Yanase et al., "Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma", JPN J CANC, 91(5), 2000, pp. 551-559
79. Enzinger, PC; Ilson, DH
    Irinotecan in esophageal cancer
    ONCOLOGY-NEW YORK
    
    P.C. Enzinger e D.H. Ilson, "Irinotecan in esophageal cancer", ONCOLOGY-NY, 14(12), 2000, pp. 26-30
80. Komaki, R; Janjan, NA; Ajani, JA; Lynch, PM; Fairweather, JS; Raijman, I; Blumenshein, GR; Ho, L; Pisters, PWT; Feig, BW; Walsh, GL; Pazdur, R
    Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors
    ONCOLOGY-NEW YORK
    
    R. Komaki et al., "Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors", ONCOLOGY-NY, 14(12), 2000, pp. 34-37
81. de Jonge, MJA; Loos, WJ; Gelderblom, H; Planting, AST; van der Burg, MEL; Sparreboom, A; Brouwer, E; van Beurden, V; Mantel, MA; Doyle, E; Hearn, S; Ross, G; Verweij, J
    Phase I pharmacologic study of oral topotecan and intravenous cisplatin: Sequence-dependent hematologic side effects
    JOURNAL OF CLINICAL ONCOLOGY
    
    M.J.A. de Jonge et al., "Phase I pharmacologic study of oral topotecan and intravenous cisplatin: Sequence-dependent hematologic side effects", J CL ONCOL, 18(10), 2000, pp. 2104-2115
82. de Jonge, MJA; Sparreboom, A; Planting, AST; van der Burg, MEL; de Boer-Dennert, MM; ter Steeg, J; Jacques, C; Verweij, J
    Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumors
    JOURNAL OF CLINICAL ONCOLOGY
    
    M.J.A. de Jonge et al., "Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumors", J CL ONCOL, 18(1), 2000, pp. 187-194
83. Vanhoefer, U; Achterrath, W; Wilke, H; Seeber, S
    Preclinical evaluation of irinotecan
    ONKOLOGIE
    
    U. Vanhoefer et al., "Preclinical evaluation of irinotecan", ONKOLOGIE, 23, 2000, pp. S2-S7
84. Tam, MN; Nam, NH; Jin, GZ; Song, GY; Ahn, BZ
    Synthesis and evaluation of the antitumor activity of 2-substituted 1,4-dihydroxy-9,10-anthraquinones
    ARCHIV DER PHARMAZIE
    
    M.N. Tam et al., "Synthesis and evaluation of the antitumor activity of 2-substituted 1,4-dihydroxy-9,10-anthraquinones", ARCH PHARM, 333(6), 2000, pp. 189-194
85. Akhtar, S; Beckman, RA; Mould, DR; Doyle, E; Fields, SZ; Wright, J
    Pretreatment with ranitidine does not reduce the bioavailability of orallyadministered topotecan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    S. Akhtar et al., "Pretreatment with ranitidine does not reduce the bioavailability of orallyadministered topotecan", CANC CHEMOT, 46(3), 2000, pp. 204-210
86. Voeller, DM; Grem, JL; Pommier, Y; Paull, K; Allegra, CJ
    Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    D.M. Voeller et al., "Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs", CANC CHEMOT, 45(5), 2000, pp. 409-416
87. Falkner, D; Wilson, J; Fertig, N; Clawson, K; Medsger, TA; Morel, PA
    Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin)
    JOURNAL OF RHEUMATOLOGY
    
    D. Falkner et al., "Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin)", J RHEUMATOL, 27(5), 2000, pp. 1196-1202
88. Akimoto, S; Abe, M; Ishikawa, O
    HLA-DRB1 and DQB1 genes in Japanese patients with systemic sclerosis
    JOURNAL OF RHEUMATOLOGY
    
    S. Akimoto et al., "HLA-DRB1 and DQB1 genes in Japanese patients with systemic sclerosis", J RHEUMATOL, 27(12), 2000, pp. 2940-2942
89. Oda, T; Kayukawa, K; Hagiwara, H; Yudate, HT; Masuho, Y; Murakami, Y; Tamura, T; Muramatsu, M
    A novel TATA-binding protein-binding protein, ABT1, activates basal transcription and has a yeast homolog that is essential for growth
    MOLECULAR AND CELLULAR BIOLOGY
    
    T. Oda et al., "A novel TATA-binding protein-binding protein, ABT1, activates basal transcription and has a yeast homolog that is essential for growth", MOL CELL B, 20(4), 2000, pp. 1407-1418
90. Johnson, MA; Bryant, PE; Jones, NJ
    Isolation of camptothecin-sensitive Chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group
    MUTAGENESIS
    
    M.A. Johnson et al., "Isolation of camptothecin-sensitive Chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group", MUTAGENESIS, 15(4), 2000, pp. 367-374
91. Longman, D; Johnstone, IL; Caceres, JF
    Functional characterization of SR and SR-related genes in Caenorhabditis elegans
    EMBO JOURNAL
    
    D. Longman et al., "Functional characterization of SR and SR-related genes in Caenorhabditis elegans", EMBO J, 19(7), 2000, pp. 1625-1637
92. Koshiyama, M; Fujii, H; Kinezaki, M; Ohgi, S; Konishi, M; Hidetaka, N; Hayashi, M; Yoshida, M
    Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrialcarcinomas: a comparison with cisplatin
    ANTICANCER RESEARCH
    
    M. Koshiyama et al., "Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrialcarcinomas: a comparison with cisplatin", ANTICANC R, 20(3A), 2000, pp. 1353-1358
93. Song, GY; Kim, Y; Zheng, XG; You, YJ; Cho, H; Chung, JH; Sok, DE; Ahn, BZ
    Naphthazarin derivatives (IV): synthesis, inhibition of DNA topoisomerase I and cytotoxicity of 2-or 6-acyl-5,8-dimethoxy-1,4-naphahoquinones
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    
    G.Y. Song et al., "Naphthazarin derivatives (IV): synthesis, inhibition of DNA topoisomerase I and cytotoxicity of 2-or 6-acyl-5,8-dimethoxy-1,4-naphahoquinones", EUR J MED C, 35(3), 2000, pp. 291-298
94. Cesarone, CF; Scarabelli, L; Demori, I; Balocco, S; Fugassa, E
    Poly(ADP-ribose) polymerase is affected early by thyroid state during liver regeneration in rats
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    
    C.F. Cesarone et al., "Poly(ADP-ribose) polymerase is affected early by thyroid state during liver regeneration in rats", AM J P-GAST, 279(6), 2000, pp. G1219-G1225
95. Taron, M; Plasencia, C; Abad, A; Martin, C; Guillot, M
    Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines
    INVESTIGATIONAL NEW DRUGS
    
    M. Taron et al., "Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines", INV NEW DR, 18(2), 2000, pp. 139-147
96. Zhou, BN; Hoch, JM; Johnson, RK; Mattern, MR; Eng, WK; Ma, J; Hecht, SM; Newman, DJ; Kingston, DGI
    Use of COMPARE analysis to discover new natural product drugs: Isolation of camptothecin and 9-methoxycamptothecin from a new source
    JOURNAL OF NATURAL PRODUCTS
    
    B.N. Zhou et al., "Use of COMPARE analysis to discover new natural product drugs: Isolation of camptothecin and 9-methoxycamptothecin from a new source", J NAT PROD, 63(9), 2000, pp. 1273-1276
97. Makinsky, AA; Kritzyn, AM; Uljanova, EA; Zakharova, OD; Nevinsky, GA
    Polymethylene derivatives of pyrimidine nucleic bases bearing omega-functional groups
    BIOORGANICHESKAYA KHIMIYA
    
    A.A. Makinsky et al., "Polymethylene derivatives of pyrimidine nucleic bases bearing omega-functional groups", BIOORG KHIM, 26(10), 2000, pp. 735-742
98. Rose, PG; Gordon, NH; Fusco, N; Fluellen, L; Rodriguez, M; Ingalls, ST; Hoppel, CL
    A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinoma
    GYNECOLOGIC ONCOLOGY
    
    P.G. Rose et al., "A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinoma", GYNECOL ONC, 78(2), 2000, pp. 228-234
99. Coleman, LW; Perkins, SL; Bronstein, IB; Holden, JA
    Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in testicular seminomas
    HUMAN PATHOLOGY
    
    L.W. Coleman et al., "Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in testicular seminomas", HUMAN PATH, 31(6), 2000, pp. 728-733
100. Gupta, D; Bronstein, IB; Holden, JA
     Expression of DNA topoisomerase I in neoplasms of the kidney: Correlation with histological grade, proliferation, and patient survival
     HUMAN PATHOLOGY
     
     D. Gupta et al., "Expression of DNA topoisomerase I in neoplasms of the kidney: Correlation with histological grade, proliferation, and patient survival", HUMAN PATH, 31(2), 2000, pp. 214-219